These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26163765)

  • 1. Environmental and chemotherapeutic agents induce breakage at genes involved in leukemia-causing gene rearrangements in human hematopoietic stem/progenitor cells.
    Thys RG; Lehman CE; Pierce LC; Wang YH
    Mutat Res; 2015 Sep; 779():86-95. PubMed ID: 26163765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of the DNA Damage Response and KMT2A Rearrangement in Fetal Liver Hematopoietic Cells.
    Nanya M; Sato M; Tanimoto K; Tozuka M; Mizutani S; Takagi M
    PLoS One; 2015; 10(12):e0144540. PubMed ID: 26657054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MLL rearrangements are induced by low doses of etoposide in human fetal hematopoietic stem cells.
    Moneypenny CG; Shao J; Song Y; Gallagher EP
    Carcinogenesis; 2006 Apr; 27(4):874-81. PubMed ID: 16377807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quercetin alters the DNA damage response in human hematopoietic stem and progenitor cells via TopoII- and PI3K-dependent mechanisms synergizing in leukemogenic rearrangements.
    Biechonski S; Gourevich D; Rall M; Aqaqe N; Yassin M; Zipin-Roitman A; Trakhtenbrot L; Olender L; Raz Y; Jaffa AJ; Grisaru D; Wiesmuller L; Elad D; Milyavsky M
    Int J Cancer; 2017 Feb; 140(4):864-876. PubMed ID: 27813122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing acute myeloid leukemia susceptibility in rearrangement-driven patients by DNA breakage at topoisomerase II and CCCTC-binding factor/cohesin binding sites.
    Atkin ND; Raimer HM; Wang Z; Zang C; Wang YH
    Genes Chromosomes Cancer; 2021 Dec; 60(12):808-821. PubMed ID: 34405474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene rearrangements of MLL and RUNX1 sporadically occur in normal CD34
    Harada Y; Shingai N; Ding Y; Sadato D; Hayashi Y; Yamaguchi M; Okuyama Y; Shimoyama T; Ohashi K; Harada H
    Cancer Sci; 2020 May; 111(5):1851-1855. PubMed ID: 32216001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.
    Lovett BD; Lo Nigro L; Rappaport EF; Blair IA; Osheroff N; Zheng N; Megonigal MD; Williams WR; Nowell PC; Felix CA
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9802-7. PubMed ID: 11493704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpoints.
    Lovett BD; Strumberg D; Blair IA; Pang S; Burden DA; Megonigal MD; Rappaport EF; Rebbeck TR; Osheroff N; Pommier YG; Felix CA
    Biochemistry; 2001 Feb; 40(5):1159-70. PubMed ID: 11170441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy-related acute myeloid leukemia-like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion.
    Libura J; Slater DJ; Felix CA; Richardson C
    Blood; 2005 Mar; 105(5):2124-31. PubMed ID: 15528316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioflavonoids promote stable translocations between MLL-AF9 breakpoint cluster regions independent of normal chromosomal context: Model system to screen environmental risks.
    Bariar B; Vestal CG; Deem B; Goodenow D; Ughetta M; Engledove RW; Sahyouni M; Richardson C
    Environ Mol Mutagen; 2019 Mar; 60(2):154-167. PubMed ID: 30387535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The broken MLL gene is frequently located outside the inherent chromosome territory in human lymphoid cells treated with DNA topoisomerase II poison etoposide.
    Glukhov SI; Rubtsov MA; Alexeyevsky DA; Alexeevski AV; Razin SV; Iarovaia OV
    PLoS One; 2013; 8(9):e75871. PubMed ID: 24086652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etoposide and illegitimate DNA double-strand break repair in the generation of MLL translocations: new insights and new questions.
    Sung PA; Libura J; Richardson C
    DNA Repair (Amst); 2006 Sep; 5(9-10):1109-18. PubMed ID: 16809075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal DNA topoisomerase II cleavage events at 5'-TATTA-3' sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing.
    Whitmarsh RJ; Saginario C; Zhuo Y; Hilgenfeld E; Rappaport EF; Megonigal MD; Carroll M; Liu M; Osheroff N; Cheung NK; Slater DJ; Ried T; Knutsen T; Blair IA; Felix CA
    Oncogene; 2003 Nov; 22(52):8448-59. PubMed ID: 14627986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoposide induces MLL rearrangements and other chromosomal abnormalities in human embryonic stem cells.
    Bueno C; Catalina P; Melen GJ; Montes R; Sánchez L; Ligero G; García-Pérez JL; Menendez P
    Carcinogenesis; 2009 Sep; 30(9):1628-37. PubMed ID: 19587093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR Gene Editing of Murine Blood Stem and Progenitor Cells Induces MLL-AF9 Chromosomal Translocation and MLL-AF9 Leukaemogenesis.
    Sarrou E; Richmond L; Carmody RJ; Gibson B; Keeshan K
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32549410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA fragile site breakage as a measure of chemical exposure and predictor of individual susceptibility to form oncogenic rearrangements.
    Lehman CE; Dillon LW; Nikiforov YE; Wang YH
    Carcinogenesis; 2017 Mar; 38(3):293-301. PubMed ID: 28069693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites.
    Broeker PL; Super HG; Thirman MJ; Pomykala H; Yonebayashi Y; Tanabe S; Zeleznik-Le N; Rowley JD
    Blood; 1996 Mar; 87(5):1912-22. PubMed ID: 8634439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary leukemias induced by topoisomerase-targeted drugs.
    Felix CA
    Biochim Biophys Acta; 1998 Oct; 1400(1-3):233-55. PubMed ID: 9748598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia.
    Strick R; Strissel PL; Borgers S; Smith SL; Rowley JD
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4790-5. PubMed ID: 10758153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11).
    Domer PH; Head DR; Renganathan N; Raimondi SC; Yang E; Atlas M
    Leukemia; 1995 Aug; 9(8):1305-12. PubMed ID: 7643617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.